Cerebral Hemodynamic Changes During Cardiac Surgery: A Feasibility MR Study in Piglets
Dominik T Schulte1, Ruth O'Gorman Tuura2, Henning Richter3
1Institute for Dynamic Systems and Control, ETH Zurich, Zurich, Switzerland.
NMR in Biomedicine
|April 5, 2026
Summary
Researchers developed an MR-conditional heart-lung machine (HLM) enabling MRI during cardiopulmonary bypass (CPB). This innovation allows in vivo study of brain metabolism and perfusion during CPB in piglets, paving the way for neuroprotection strategies.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Pediatric Cardiology
Background:
- Congenital heart disease necessitates surgical intervention, often involving cardiopulmonary bypass (CPB).
- Infants undergoing CPB face increased risk of white matter injury, impacting neurodevelopment, with unclear mechanisms.
- Conventional heart-lung machines (HLMs) interfere with MR imaging, hindering in vivo studies of brain changes during CPB.
Purpose of the Study:
- To develop and evaluate an MR-conditional HLM for simultaneous MR imaging and CPB in a preclinical model.
- To assess the feasibility of monitoring cerebral perfusion and metabolism during CPB within an MR scanner.
Main Methods:
- An MR-conditional HLM, including a roller pump, was developed and tested.
- Piglets underwent CPB inside an MR scanner, with cooling, rewarming, and carotid clamping.
- In vivo MR imaging (flow, diffusion, perfusion, metabolism) was performed during CPB.
Main Results:
- The MR-conditional HLM operated effectively inside the scanner without compromising imaging or pump function.
- Key brain structures were visualized without artifacts, and monitoring signals remained stable.
- MR scans indicated flow-related changes and increased lactate, suggesting metabolic stress under hypoperfusion.
Conclusions:
- Performing CPB within an MR scanner using an MR-conditional HLM is technically feasible.
- This platform enables mechanistic studies of brain injury during CPB in large-animal models.
- Future applications include identifying early markers of cerebral vulnerability and developing neuroprotective strategies.


